logo

HomeArticlesServicePriceAbout

EN

Menu

Home
Articles
Service
Price
Search
About
EN
logo
logo

Company

AboutTerms of Service Privacy Policy

Social

LinkedIn Twitter Discord

Contact

contact@coresixteen.com coresixteen.com
Company NameCORE16 Inc.
CEODavid Cho
Business Registration Number762-81-03235
officePhone070-4225-0201
Address83, Uisadang-daero, Yeongdeungpo-gu, Seoul, 07325, Republic of KOREA
Illumina
Search Result
Firm
user
박재훈투영인
·
6 months ago
0
0
FTC Orders Illumina to Divest Grail(Apr 3, 2023)
article
Strong Sell
Strong Sell
ILMN
Illumina
user
박재훈투영인
·
6 months ago
0
0
FTC Orders Illumina to Divest Grail(Apr 3, 2023)
In 2021, Illumina, the leading manufacturer of gene-sequencing technology, completed its acquisition of Grail, a promising cancer-test developer, in a transaction valued at $7.1 billion. Grail originated as a research project within Illumina before being spun out as an independent company in 2016. The company has developed innovative technology for early detection of various cancers, including pancreatic, head and neck, and ovarian cancers.The Federal Trade Commission (FTC) has recently ordered Illumina to divest Grail, marking a significant development in antitrust regulation. This decision follows a similar ruling by the European Union last September, which also blocked the deal. The FTC's decision was unanimous, with commissioners voting 4-0 to reverse a previous ruling by an administrative law judge who had initially ruled in Illumina's favor.In its official statement, the FTC concluded that the acquisition would "diminish innovation in the U.S. market for multicancer early-detection tests while increasing prices and decreasing choice and quality of tests." The commission also expressed concerns that Illumina could leverage its dominant position as the leading supplier of gene-sequencing services to undermine Grail's competitors by "raising their costs or withholding or degrading access to supply, service or new technologies."Illumina has indicated its intention to appeal both the FTC ruling and the European decision in federal appeals court. However, the company has stated that if these appeals prove unsuccessful, it will "move expeditiously" to divest Grail.The prolonged uncertainty surrounding Grail's fate has negatively impacted Illumina's financial performance, with the company's stock price declining by approximately 37% over the past year. Prior to recent developments, Illumina shares were trading below $200, but have since shown marginal movement, closing at $230 per share after the FTC announcement.Adding to Illumina's challenges, activist investor Carl Icahn has initiated a proxy fight against the current management team. Icahn has characterized the Grail acquisition as an "overpriced mistake" and has advocated for the return of former CEO Jay Flatley to replace current chief executive Francis deSouza, who was the principal architect of the Grail acquisition.According to antitrust experts, this case extends well beyond a single biotech transaction and represents a test of regulators' renewed efforts to prevent large companies from acquiring emerging innovators. Both European and American regulators have adopted increasingly aggressive stances toward such acquisitions.The case is particularly noteworthy because Grail does not directly compete with Illumina in gene sequencing—it represents what is known as a "vertical acquisition." Historically, courts have been reluctant to block or unwind such deals. If the FTC's challenge is upheld by the courts, it could significantly impact future acquisition strategies by tech giants and other dominant companies, potentially leading to additional divestiture orders.FTC Chair Lina Kahn, a prominent advocate for pre-emptive regulatory action in merger oversight, has made this case a centerpiece of the commission's more assertive approach to antitrust enforcement.
article
Strong Sell
Strong Sell
ILMN
Illumina
Economy & Strategy
user
박재훈투영인
·
5 months ago
0
0
Nasdaq 100 Index Overview (Feb 18, 2025)
article
Neutral
Neutral
NONE
No Relevant Stock
user
박재훈투영인
·
5 months ago
0
0
Nasdaq 100 Index Overview (Feb 18, 2025)
History & EvolutionThe Nasdaq 100 Index, introduced in 1985, tracks the performance of the top 100 non-financial companies listed on the Nasdaq stock exchange. As the first electronic stock market in 1971, Nasdaq became a hub for technological innovation, and the Nasdaq 100 has since served as a benchmark for large-cap growth companies.Technology Sector DominanceAs of 2025, the technology sector makes up 62.25% of the Nasdaq 100, led by Apple, Microsoft, and NVIDIA. Companies like Amazon and Tesla, though categorized in different sectors, operate technology-driven businesses, further solidifying Nasdaq’s tech-heavy nature. The ongoing AI and digital transformation boom continues to drive the index, making sector concentration risk and rebalancing impact key factors for investors.Nasdaq’s Competitive Edge in IPOsNasdaq has outperformed NYSE in IPO listings for six consecutive years through 2024. Over 160 companies raised $22 billion on Nasdaq in 11 months of 2024, reflecting growing preference among tech-driven firms. AI-related firms' rapid expansion has further fueled Nasdaq’s dominance in public listings.Inclusion & Exclusion CriteriaCompanies must be exclusively listed on the Nasdaq Global Select Market, maintain high liquidity, and have a minimum 3-month trading history.Financial firms & REITs are excluded.Annual index rebalancing adjusts the composition, removing underperforming stocks.In 2024, Super Micro Computer, Illumina, and Moderna were removed from the index.Nasdaq 100 vs. S&P 500QQQ ETF tracks Nasdaq 100, with a 62.25% tech weighting, making it more volatile.S&P 500 covers 500 companies, offering a more diversified portfolio with lower volatility.Market Performance & Growth TrendsNasdaq 100 experienced major events such as the dot-com bubble (2000), the financial crisis (2008), and AI-driven expansion (2024).After an 800% rise from 1995-2000, the dot-com crash led to a 76.81% decline.The index only recovered its 2000 peak in 2015, but today’s AI-driven rally differs due to companies' strong profitability & financial stability.Innovation & Economic ImpactNasdaq defines innovation as a driver of economic value, knowledge integration, and real-world impact. R&D spending and patent filings serve as key indicators, expanding beyond technology to include healthcare, consumer goods, and other industries.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.
article
Neutral
Neutral
NONE
No Relevant Stock